市場調查報告書
商品編碼
1530834
2030 年醫療保健自動化市場預測:按技術、應用、最終用戶和地區進行的全球分析Healthcare Automation Market Forecasts to 2030 - Global Analysis By Technology (Robotics, Artificial Intelligence, Internet of Medical Things, Big Data and Analytics, Blockchains and Other Technologies), Application, End User and by Geography |
根據 Stratistics MRC 的數據,2024 年全球醫療保健自動化市場規模為 441.5 億美元,預測期內複合年成長率為 12.0%,到 2030 年將達到 871.5 億美元。
醫療保健自動化一詞描述了應用軟體和技術來自動執行重複性任務並改善醫療產業的工作流程。這些範圍從自動申請和電子健康記錄( EHR) 管理到先進的機器人手術和人工智慧驅動的診斷。醫療保健提供者可以透過自動化耗時且重複的任務來提高工作效率、減少錯誤並花更多時間患者照護。此外,自動化提高了資料的可及性和準確性,有助於更好的決策並改善患者的治療結果。
據美國醫學會稱,醫療保健自動化有可能顯著減輕醫生的行政負擔,使他們能夠更加專注於直接患者護理和改善整體醫療保健服務。
對有效醫療服務的需求不斷成長
人口老化、慢性病的流行以及患者期望的提高都導致醫療保健領域服務需求的增加。醫療保健提供者面臨著滿足這些需求並提供有效、高品質護理的壓力。自動化技術有助於管理患者負擔、減少等待時間並確保及時的醫療干預。此外,醫療保健自動化最佳化了工作流程並減輕了管理負擔,使醫務人員能夠更多地關注患者照護,最終改善患者的治療結果。
高入門價
實施醫療保健自動化技術需要在硬體、軟體和基礎設施方面進行大量初始投資。對於預算有限的小型診所和設施來說,這些費用可能令人望而卻步。此外,與員工培訓、系統維護以及與當前技術整合相關的成本也增加了負擔。此外,雖然從長遠來看,自動化可以提高效率並降低成本,但它可能會帶來巨大的前期成本,特別是對於資源不足或偏遠的醫療保健提供者而言。
醫學研究的新方法
醫學研究將透過自動化取得巨大進步。自動化資料收集和分析可以縮短臨床試驗和研究的時間。醫療領域的巨量資料可以透過人工智慧和機器學習演算法進行處理,以揭示人類無法揭示的趨勢和見解。結果,可能會發現新的治療方法、藥物和治療方法。自動化也有助於確保研究資料管理的準確性和法規遵循。
法律和道德問題
醫療保健領域的自動化,特別是人工智慧和機器學習的應用,帶來了重大的道德和法律問題。必須仔細考慮演算法偏差、自動決策的透明度以及人工智慧系統的課責等問題。例如,如果AI系統出現診斷錯誤,則很難確定責任和課責。確保自動化系統的開發和使用符合道德規範,需要不斷審查、相關人員的全面參與、制定精確的道德標準以及法律體制的實施。此外,平衡自動化的好處與道德考量對於維持醫療保健服務的公平和信任至關重要。
COVID-19 大流行為世界各地的醫療保健系統帶來了前所未有的挑戰,導致醫療保健自動化的採用顯著加速。遠端醫療平台、自動化診斷工具和遠端監控系統的快速部署推動了對有效且可擴展的解決方案的需求,以管理患者照護、減少醫護人員的工作量並確保服務的連續性。此外,自動化簡化了管理流程,實現了遠端患者交互,並改善了資料管理,減輕了負擔過重的醫療機構的壓力。
人工智慧產業預計將在預測期內成為最大的產業
人工智慧(AI)領域在醫療保健自動化市場中佔有最大佔有率。人工智慧在個人化醫療、診斷和治療計劃方面的廣泛應用正在推動其主導地位。人工智慧系統能夠以無與倫比的精度評估複雜的醫療資料、提供預後預測並增強決策程序。這包括處理醫療記錄的自然語言處理、預測患者結果的預測分析以及放射學中的影像識別等應用。此外,人工智慧 (AI) 因其適應性和改變醫療保健營運和交付的許多方面的能力而成為醫療保健自動化發展的主要參與者。
診斷監控自動化產業預計在預測期內複合年成長率最高
在醫療保健自動化市場中,診斷和監測自動化領域的複合年成長率最高。對先進診斷設備和持續病患監測計劃不斷成長的需求正在推動該市場的爆炸性成長。穿戴式健康監測器、人工智慧驅動的診斷系統和遙感探測技術只是改變醫療保健專業人員識別和治療疾病方式的創新的幾個例子。此外,這些技術提供即時資料、提高診斷準確性並能夠主動管理健康狀況,正在推動大量投資和領域擴張。
醫療保健自動化市場由北美主導。這一優勢得益於該地區自動化解決方案的高採用率、大量的技術投資和先進的醫療基礎設施。由於重要科技公司的存在、大量的研發計劃以及促進商業發展的政府法規,北美仍保持領先地位。此外,該地區在醫療保健自動化領域的巨大市場佔有率是由該行業對創新解決方案的強勁需求、穩定的法規環境以及改善患者治療結果和醫療保健效率的承諾所推動的。
歐洲的醫療保健自動化市場也以相當快的速度擴張,複合年成長率最高。這一成長是由該地區日益關注醫療保健的技術創新和數位轉型所推動的。為了應對人口老化帶來的挑戰、提高業務效率並提高護理質量,歐洲國家正在大力投資尖端自動化技術。此外,歐盟的支持性法規環境、大量的研發資金以及綜合衛生系統的推廣進一步加速了自動化解決方案的採用。
According to Stratistics MRC, the Global Healthcare Automation Market is accounted for $44.15 billion in 2024 and is expected to reach $87.15 billion by 2030 growing at a CAGR of 12.0% during the forecast period. The term healthcare automation describes the application of software and technology to automate repetitive tasks and improve workflow in the medical industry. This can range from automated billing and the administration of electronic health records (EHRs) to sophisticated robotic surgery and AI-driven diagnostics. Healthcare providers can increase productivity, lower errors, and devote more time to patient care by automating time-consuming and repetitive tasks. Additionally, automation improves the accessibility and accuracy of data, which facilitates better decision-making and better patient outcomes.
According to the American Medical Association, healthcare automation has the potential to significantly reduce administrative burdens on physicians, allowing them to focus more on direct patient care and improving overall healthcare delivery.
Growing need for effective medical services
The aging population, the prevalence of chronic diseases, and the rising expectations of patients are all contributing factors to the growing demand for services in the healthcare sector. Healthcare providers are under pressure to provide effective, high-quality care in response to this demand. Automation technologies help to manage patient loads, shorten wait times, and guarantee prompt medical interventions. Moreover, healthcare automation helps medical staff focus more on patient care by optimizing workflows and lowering administrative burdens, which eventually improves patient outcomes.
High starting prices
Healthcare automation technology implementation necessitates a large initial hardware, software, and infrastructure investment. These expenses may be unaffordable for smaller medical practices and facilities with tighter budgets. The costs associated with employee training, system maintenance, and integration with current technologies can also increase the burden. Furthermore, automation may increase efficiency and reduce costs in the long run, but it can come with a significant upfront cost, especially for underfunded or remote healthcare providers.
New approaches to medical research
Medical research can progress significantly with the help of automation. Clinical trial and research study times can be shortened by using automated data collection and analysis. Big data in the medical field can be processed by AI and machine learning algorithms, which can reveal trends and insights that are impossible for humans to see. Novel therapies, medications, and treatments may be found as a result of this. Automation also helps to ensure accuracy and regulatory compliance in the management of research data.
Legal and ethical concerns
The application of automation in healthcare, especially AI and machine learning, presents significant moral and legal issues. Careful consideration must be given to matters like algorithmic bias, automated decision-making transparency, and AI system accountability. Determining liability and accountability, for instance, can be difficult if an AI system makes a diagnostic error. It takes constant examination, inclusive stakeholder engagement, the development of precise ethical standards, and the implementation of legal frameworks to guarantee that automated systems are developed and utilized ethically. Additionally, to preserve equity and trust in the provision of healthcare, it is crucial to strike a balance between the advantages of automation and moral considerations.
The COVID-19 pandemic brought about unprecedented challenges for healthcare systems worldwide, which in turn significantly accelerated the adoption of healthcare automation. The quick adoption of telehealth platforms, automated diagnostic tools, and remote monitoring systems was motivated by the need for effective and scalable solutions to manage patient care, lessen the workload on healthcare professionals, and ensure continuity of services. Furthermore, automation streamlined administrative processes, enabled remote patient interactions, and improved data management, all of which relieved pressure on overburdened healthcare facilities.
The Artificial Intelligence segment is expected to be the largest during the forecast period
In the market for healthcare automation, the artificial intelligence (AI) segment has the largest share. The wide range of uses of AI in personalized medicine, diagnosis, and treatment planning is what propels its dominance. AI systems possess the ability to evaluate intricate medical data, offer prognostications, and bolster decision-making procedures with unparalleled precision. This covers uses like natural language processing for processing medical records, predictive analytics for patient outcomes, and image recognition in radiology. Moreover, artificial intelligence (AI) is a key player in the growth of healthcare automation due to its adaptability and capacity to change many facets of healthcare operations and delivery.
The Diagnostics & Monitoring Automation segment is expected to have the highest CAGR during the forecast period
In the healthcare automation market, the Diagnostics & Monitoring Automation segment has the highest CAGR. The rising need for sophisticated diagnostic instruments and ongoing patient monitoring programs is driving this market's explosive expansion. Wearable health monitors, AI-driven diagnostic systems, and remote sensing technologies are just a few examples of innovations that are changing the way healthcare professionals identify and treat illnesses. Additionally, significant investment and sector expansion are being driven by these technologies, which provide real-time data, enhance diagnostic accuracy, and enable proactive management of health conditions.
The market for healthcare automation is dominated by North America. This dominance is a result of the region's highly adopted automation solutions, substantial technological investments, and sophisticated healthcare infrastructure. North America is still in the lead because of the existence of significant technology companies, a plethora of R&D projects, and pro-business government regulations. Furthermore, the region's sizable market share in healthcare automation is also attributed to the strong demand for creative solutions in the field, a stable regulatory environment, and a commitment to enhancing patient outcomes and healthcare efficiency.
The healthcare automation market is expanding at a significant rate in Europe as well, with the highest CAGR. The region's growing focus on technology innovation and the digital transformation of healthcare is what is causing this growth. In order to address the issues posed by an aging population, increase operational efficiencies, and improve care quality, European nations are making significant investments in cutting-edge automation technologies. Moreover, the adoption of automation solutions is being further fueled by the EU's supportive regulatory environment, significant funding for research and development, and the push for integrated healthcare systems.
Key players in the market
Some of the key players in Healthcare Automation market include Swisslog Holding AG, Cerner, Stryker Corporation, Accuray, Inc., Tecan Group Ltd., Koninklijke Philips N.V., GE Healthcare, Roche Diagnostics, Intuitive Surgical, Inc., Danaher Corporation, Siemens Healthineers, Medtronic plc and Philips Healthcare.
In July 2024, GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC's (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for total consideration of approximately $51 million. Intelligent Ultrasound is a leader in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient.
In June 2024, Accuray Incorporated announced an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities.
In June 2024, Stryker, a global leader in medical technologies, announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.